Applied DNA Sciences APDN reported its Q1 earnings results on Thursday, February 8, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Applied DNA Sciences beat estimated earnings by 70.97%, reporting an EPS of $-0.09 versus an estimate of $-0.31.
Revenue was down $4.37 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 18.43% drop in the share price the next day.
Here's a look at Applied DNA Sciences's past performance:
Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
---|---|---|---|---|
EPS Estimate | -0.27 | -0.24 | -0.2 | -0.29 |
EPS Actual | -0.26 | -0.24 | -0.2 | -0.30 |
Revenue Estimate | 1.60M | 2.56M | 4.12M | 4.17M |
Revenue Actual | 779K | 2.92M | 4.41M | 5.26M |
To track all earnings releases for Applied DNA Sciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.